We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Inter-amer 30 | LSE:BC43 | London | Medium Term Loan |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0 | - |
BW20020923002229 20020923T230506Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Re Alliance Business Editors UK REGULATORY NEWS LONDON--(BUSINESS WIRE)--Sept. 23, 2002-- InnoCentive Accelerates Expansion into Fast-Growing Scientific Community in India InnoCentive Partners with the Indian Institute of Chemical Engineers (IIChE) at IndiaChem 2002 Conference InnoCentive(TM) today announced a partnership with the Indian Institute of Chemical Engineers (IIChE) at the IndiaChem 2002 conference. InnoCentive provides an online forum that allows world-class scientists and innovation-driven companies to collaborate in a global scientific community to solve difficult R&D problems. "We are very committed to expanding InnoCentive's presence in India and its large and fast-growing scientific community," said Darren Carroll, chief executive officer of InnoCentive. "Our association with IIChE will further enhance our solver base, and provide more scientific solutions to innovation-driven companies worldwide." Carroll noted that IIChE is one of the oldest and most prestigious scientific organizations in India, and it boasts over 18,000 members from academia, industry, and research institutes world-wide. Among its many activities, IIChE administers the Indian national qualifying examination for chemical engineers, and publishes the oldest refereed scientific journal in India. "Collaboration between IIChE and InnoCentive will provide an international platform to Indian chemical engineers for the productive use of their creative skills" said Dr. S.K. Sharma, president of the IIChE. "It will also generate synergy between a leading powerhouse of innovations and one of the largest professional societies of chemical engineers in Asia facing the challenges of science and technology for the welfare of the society." InnoCentive has also joined forces with the Council of Scientific and Industrial Research (CSIR), the largest research and development organization in India and one of the largest in the world. All CSIR scientists can work on InnoCentive scientific challenges, which raise the potential for this talented group of Indian scientists to achieve international recognition and financial rewards. "InnoCentive offers an attractive opportunity for Indian scientists to solve scientific challenges from world-class companies and to be recognized for their expertise," said Ali Hussein, vice president of marketing for InnoCentive. "We are very much looking forward to working with some of the best and most proven scientists in the world in India." About InnoCentive InnoCentive is the first online forum that allows world-class scientists and science-based companies to collaborate in a global scientific community to achieve innovative solutions to complex challenges. InnoCentive is an e-business venture of Eli Lilly and Company, a leading innovation-driven pharmaceutical company. To learn more, visit the InnoCentive web site at www.innocentive.com. Short Name: Lilly (Eli) & Co Category Code: SAL Sequence Number: 00000823 Time of Receipt (offset from UTC): 20020923T230758+0100 --30--kk/ny* CONTACT: InnoCentive, Inc. Lori Costa, 978/482-3306 KEYWORD: INDIA UNITED KINGDOM INTERNATIONAL ASIA PACIFIC EUROPE INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL INTERNET E-COMMERCE SOURCE: Lilly (Eli) & Co Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: http://www.businesswire.com
1 Year Inter-amer 30 Chart |
1 Month Inter-amer 30 Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions